Should You Buy Dexcom Stock After Its Downbeat Q4?
- Tuesday, February 15, 2022, 7:12
- Market
- Add a comment
The stock price of Dexcom, best known for its continuous glucose monitoring systems, has seen a drop of 8% over the last month, while it was down 5% on Friday, Feb 11, due to the company’s downbeat Q4 results. Dexcom’s revenue of $698.5 million was slightly above the consensus estimate…
About the Author
admin123 has written 23527 stories on this site.
